Danaher beats profit estimates on respiratory testing demand

Go back to Danaher beats profit estimates on respiratory testing demand

Danaher (DHR) revenue tops expectations on strong respiratory testing demand

October 24, 2023 9:22 AM EDT

Danaher (NYSE: DHR) shares fell over 2% Tuesday despite the company's third-quarter earnings and revenue topping consensus expectations.

The company reported Q3 EPS of $2.02, $0.25 better than the analyst estimate of $1.77, while revenue for the quarter came in at $6.9 billion, down 10.5% YoY, but above the... More